Cogent Biosciences Inc. logo

Cogent Biosciences Inc.

COGT | NASDAQ
Chart Builder DCF Calculator
$32.24
+$0.24 (+0.75%)
Sep 22, 2026, 12:44 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
312.01M 98.17M 53.23M 139.89M 219.68M 242.19M
Short-Term Investments
588.75M 188.91M 212.48M 119.39M n/a n/a
Long-Term Investments
n/a n/a 7.46M n/a 1.26M n/a
Other Long-Term Assets
3.72M 4.86M 4.86M 4.75M 3.73M 1.26M
Receivables
n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
9.59M 9.4M 5.06M 1.26M n/a n/a
Total Current Assets
910.36M 296.47M 270.77M 264.97M 222.63M 244.91M
Property-Plant & Equipment
23.54M 26.56M 30.34M 31.1M 4.48M 4.75M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
27.25M 31.43M 42.67M 35.84M 9.46M 6M
Total Assets
937.61M 327.9M 313.44M 300.81M 232.09M 250.92M
Account Payables
9.5M 12.01M 10.66M 5.84M 3.48M 732K
Deferred Revenue
n/a n/a n/a 1.7M 3.06M n/a
Short-Term Debt
1.55M n/a n/a n/a n/a n/a
Other Current Liabilities
52.9M 12.63M 10.32M 6.47M 3.62M 7.28M
Total Current Liabilities
63.95M 55.71M 38.17M 26.85M 17.08M 13.09M
Long-Term Debt
237.25M n/a n/a n/a n/a n/a
Other Long-Term Liabilities
-14.32M n/a n/a n/a n/a n/a
Total Long-Term Liabilities
237.28M 15.9M 17.47M 18.23M 831K 3.16M
Total Liabilities
301.24M 71.61M 55.64M 45.08M 17.91M 16.25M
Total Debt
253.15M 17.47M 18.85M 19.65M 3.16M 5.21M
Book Value
636.37M 256.29M 257.8M 255.74M 214.18M 234.67M
Book Value Per Share
3.95 2.32 3.24 4.35 5.53 21.18
Common Stock
161K 110K 86K 70K 44K 32K
Retained Earnings
-1.19B -859.48M -603.62M -411.21M -270.97M -198.7M
Comprehensive Income
355K 447K 246K -104K 0 n/a
Shareholders Equity
636.37M 256.29M 257.8M 255.74M 214.18M 234.67M
Total Investments
588.75M 188.91M 219.94M 119.39M 1.26M n/a

© 2026 bestshares.com. All rights reserved.